Opportunity Information: Apply for CDC RFA TS19 19010301SUPP21
The Pediatric Environmental Health Specialty Unit (PEHSU): Expansion Supplement is a federal cooperative agreement funding opportunity from the Agency for Toxic Substances and Disease Registry (ATSDR) within the Centers for Disease Control and Prevention (CDC), under the U.S. Department of Health and Human Services. The grant is designed to maintain, strengthen, and expand the national PEHSU network, which serves as a key source of medical information and consultative support on environmental exposures and conditions that can affect health, especially during sensitive periods such as preconception, pregnancy, infancy, childhood, and adolescence. The overall intent is to reinforce PEHSU as a national clinical and public health resource that helps health professionals, communities, and partners understand and respond to environmental health risks impacting children and families.
A major focus of the opportunity is strengthening coordination and collaboration among ATSDR, the U.S. Environmental Protection Agency (EPA), and the PEHSU National Program Office (NPO). The recipient funded under this supplement is expected to lead and manage the day-to-day operations of the national PEHSU network through the NPO role, and to work closely with each regional PEHSU. In practice, this means supporting consistent network performance, helping regional units share tools and best practices, aligning activities to national priorities, and ensuring the network meets program goals and achieves measurable health outcomes. Because this is a cooperative agreement, the federal agency is not simply issuing funds and stepping back; it signals ongoing involvement and collaboration with the awardee in implementing the program.
The NOFO also requires two specific program components that the recipient must deliver as part of the expanded work. Component 1 centers on building capacity among health professionals and environmental justice or otherwise disadvantaged communities to address childrens environmental health risks associated with COVID-19. This component reflects the idea that the pandemic intersects with environmental health in ways that can worsen inequities, such as differences in housing quality, exposure to indoor air pollutants, community-level pollution burdens, access to health care, and the ability to reduce exposures. The expected direction is workforce and community capacity-building, which typically includes training, technical assistance, and practical guidance that equips clinicians and community partners to recognize, communicate about, and reduce environmental risks affecting children in the context of COVID-19.
Component 2 requires the development of educational materials focused on per- and poly-fluoroalkyl substances (PFAS) for health care professionals and students. The purpose is to raise awareness of potential PFAS-related health impacts and to strengthen clinicians ability to provide risk mitigation guidance to patients. In other words, the supplement is pushing the network to translate PFAS science into usable clinical and educational products, so providers can better answer patient questions, interpret exposure concerns, and offer realistic steps to reduce risk when appropriate. The emphasis on both practicing professionals and students suggests an intention to influence current clinical practice while also improving longer-term competency in the health workforce.
Administratively, this opportunity was listed as discretionary funding using a cooperative agreement mechanism, categorized under health, with CFDA number 93.161. It was released June 16, 2021, with an original application deadline of July 30, 2021 (applications due by 11:59 pm ET). The anticipated funding structure included an award ceiling of $3,500,000 and an expectation of a single award, indicating ATSDR intended to fund one lead recipient to operate the NPO and coordinate the national network rather than distributing multiple separate awards for the national office function. Eligibility is described broadly as "Others" with additional eligibility details referenced in the full announcement, implying that applicants needed to consult the NOFO text for specific organizational eligibility requirements.
Taken together, the PEHSU Expansion Supplement is essentially a national network-strengthening and targeted expansion effort: it supports continued operation and improvement of the PEHSU system, deepens federal partner coordination with ATSDR and EPA, and adds two focused deliverables aimed at urgent and high-priority environmental health topics, namely COVID-19-related pediatric environmental health risks in environmental justice and disadvantaged communities, and PFAS education to improve clinical awareness and patient guidance.Apply for CDC RFA TS19 19010301SUPP21
- The Department of Health and Human Services, Centers for Disease Control - ATSDR in the health sector is offering a public funding opportunity titled "Pediatric Environmental Health Specialty Unit (PEHSU): Expansion Supplement" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.161.
- This funding opportunity was created on Jun 16, 2021.
- Applicants must submit their applications by Jul 30, 2021 Electronically submitted applications must be submitted no later than 1159 pm ET on the listed application due date.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $3,500,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs): Pediatric Environmental Health Specialty Unit (PEHSU) Expansion Supplement
1) What is the PEHSU: Expansion Supplement funding opportunity?
The Pediatric Environmental Health Specialty Unit (PEHSU): Expansion Supplement is a federal cooperative agreement funding opportunity from the Agency for Toxic Substances and Disease Registry (ATSDR) within the Centers for Disease Control and Prevention (CDC), under the U.S. Department of Health and Human Services. Its purpose is to maintain, strengthen, and expand the national PEHSU network as a clinical and public health resource on environmental exposures and conditions affecting health, especially during sensitive life stages.
2) Which federal agency is offering this cooperative agreement?
The opportunity is offered by ATSDR, which sits within CDC, under the U.S. Department of Health and Human Services.
3) What is the main goal of this supplement?
The overall intent is to reinforce PEHSU as a national clinical and public health resource that helps health professionals, communities, and partners understand and respond to environmental health risks impacting children and families. It emphasizes strengthening and expanding the national PEHSU network and achieving measurable health outcomes.
4) What is the PEHSU network meant to do?
The national PEHSU network serves as a key source of medical information and consultative support related to environmental exposures and conditions that can affect health. The focus is especially strong for sensitive periods including preconception, pregnancy, infancy, childhood, and adolescence.
5) What makes this a cooperative agreement rather than a standard grant?
This opportunity uses a cooperative agreement mechanism, which signals that the federal agency expects ongoing involvement and collaboration with the awardee during implementation, rather than simply providing funding and stepping back.
6) What is expected of the recipient in terms of national leadership?
The funded recipient is expected to lead and manage the day-to-day operations of the national PEHSU network through the PEHSU National Program Office (NPO) role, working closely with each regional PEHSU.
7) What is the role of the PEHSU National Program Office (NPO) under this supplement?
The recipient, acting through the NPO role, is expected to support consistent network performance; help regional PEHSUs share tools and best practices; align activities with national priorities; and help ensure the network meets program goals and achieves measurable health outcomes.
8) Which partner organizations are emphasized for coordination and collaboration?
A major focus is strengthening coordination and collaboration among ATSDR, the U.S. Environmental Protection Agency (EPA), and the PEHSU National Program Office (NPO), alongside close coordination with each regional PEHSU.
9) How many awards were expected to be made?
The anticipated structure described an expectation of a single award, indicating the intent to fund one lead recipient to operate the NPO and coordinate the national network.
10) What is the maximum funding amount mentioned for this opportunity?
The anticipated award ceiling listed is $3,500,000.
11) What are the two required program components in the expanded work?
The NOFO requires two specific components: (1) capacity-building focused on childrens environmental health risks associated with COVID-19, with emphasis on health professionals and environmental justice or otherwise disadvantaged communities; and (2) development of educational materials focused on PFAS for health care professionals and students.
12) What is Component 1 about?
Component 1 centers on building capacity among health professionals and environmental justice or otherwise disadvantaged communities to address childrens environmental health risks associated with COVID-19. The premise is that COVID-19 can intersect with environmental health and worsen inequities, including differences in housing quality, indoor air pollutant exposures, community-level pollution burdens, access to health care, and the ability to reduce exposures.
13) What types of activities are implied under Component 1?
The expected direction is workforce and community capacity-building, which typically includes training, technical assistance, and practical guidance to help clinicians and community partners recognize, communicate about, and reduce environmental risks affecting children in the context of COVID-19.
14) Who is the intended audience for the COVID-19 capacity-building work?
The audience highlighted includes health professionals and environmental justice or otherwise disadvantaged communities.
15) What is Component 2 about?
Component 2 requires developing educational materials focused on per- and poly-fluoroalkyl substances (PFAS) for health care professionals and students, aimed at increasing awareness of potential PFAS-related health impacts and strengthening clinicians ability to provide risk mitigation guidance to patients.
16) Who is the intended audience for the PFAS educational materials?
The materials are intended for health care professionals and students, reflecting an intent to influence current clinical practice while also supporting longer-term workforce competency.
17) What is the practical purpose of the PFAS education deliverable?
The emphasis is on translating PFAS science into usable clinical and educational products so providers can better answer patient questions, interpret exposure concerns, and offer realistic steps to reduce risk when appropriate.
18) What topic areas does the supplement prioritize?
It prioritizes (a) childrens environmental health risks associated with COVID-19, particularly as they relate to inequities affecting environmental justice and disadvantaged communities, and (b) PFAS education for clinicians and students.
19) What is the funding category and mechanism?
The opportunity is described as discretionary funding using a cooperative agreement mechanism, categorized under health.
20) What CFDA number is associated with this opportunity?
The CFDA number listed is 93.161.
21) When was the opportunity released?
The opportunity was released on June 16, 2021.
22) What was the original application deadline and time zone?
The original application deadline was July 30, 2021, with applications due by 11:59 pm ET.
23) What is stated about eligibility?
Eligibility is described broadly as "Others," with additional eligibility details referenced in the full announcement. Applicants would need to consult the NOFO for the specific organizational eligibility requirements.
24) What does the opportunity suggest about how the national PEHSU work is organized?
It suggests a model where one lead recipient operates the National Program Office to coordinate the national network, while working closely with each regional PEHSU to support consistent performance, shared tools and best practices, alignment to national priorities, and progress toward program goals and measurable outcomes.
25) What populations or life stages are explicitly highlighted as sensitive?
The description explicitly highlights sensitive periods such as preconception, pregnancy, infancy, childhood, and adolescence.
Browse more opportunities from the same category: Health
Next opportunity: Corrections Podcast Series
Previous opportunity: Short Documentaries
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA TS19 19010301SUPP21
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA TS19 19010301SUPP21) also looked into and applied for these:
| Funding Opportunity |
|---|
| Strengthening environmental health capacity (EHC) to detect, prevent, and control environmental health hazards through data-driven, evidence-based approaches; pilot Environmental Health Records EHR/COVID-19 community mitigation Apply for CDC RFA EH20 20050101SUPP21 Funding Number: CDC RFA EH20 20050101SUPP21 Agency: Department of Health and Human Services, Centers for Disease Control - NCEH Category: Health Funding Amount: $250,000 |
| Strategic Planning: South America Apply for CDC RFA CD21 2102 Funding Number: CDC RFA CD21 2102 Agency: Department of Health and Human Services, Centers for Disease Control - OD Category: Health Funding Amount: Case Dependent |
| Strategic Planning: Eastern Europe/Central Asia Apply for CDC RFA CD21 2103 Funding Number: CDC RFA CD21 2103 Agency: Department of Health and Human Services, Centers for Disease Control - OD Category: Health Funding Amount: Case Dependent |
| Short-Term Research Education Program to Enhance Diversity in Health-Related Research (R25 Clinical Trial Not Allowed) Apply for RFA HL 22 012 Funding Number: RFA HL 22 012 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: $154,000 |
| Strategic Planning: Southeast Asia Apply for CDC RFA CD21 2105 Funding Number: CDC RFA CD21 2105 Agency: Department of Health and Human Services, Centers for Disease Control - OD Category: Health Funding Amount: Case Dependent |
| Strategic Planning: Middle East/North Africa Apply for CDC RFA CD21 2104 Funding Number: CDC RFA CD21 2104 Agency: Department of Health and Human Services, Centers for Disease Control - OD Category: Health Funding Amount: Case Dependent |
| Minority Leaders Development Program Apply for MP CPI 21 008 Funding Number: MP CPI 21 008 Agency: Department of Health and Human Services, Office of the Assistant Secretary for Health Category: Health Funding Amount: $750,000 |
| Global Reach II Apply for HRSA 21 144 Funding Number: HRSA 21 144 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Data Enhancements and Analyses to Clarify the Relationship between Education and Cognitive Function (including AD/ADRD) (R01 Clinical Trial Not Allowed) Apply for RFA AG 22 025 Funding Number: RFA AG 22 025 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Patient Safety Learning Laboratories: Advancing Patient Safety through Design, Systems Engineering, and Health Services Research (R18 Clinical Trial Optional) Apply for PA 21 266 Funding Number: PA 21 266 Agency: Department of Health and Human Services, Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| Enhancing Public Health Laboratory Capabilities and Increasing Capacity Apply for CDC RFA OE20 20010203SUPP21 Funding Number: CDC RFA OE20 20010203SUPP21 Agency: Department of Health and Human Services, Centers for Disease Control - CSELS Category: Health Funding Amount: $40,000,000 |
| Center for Indigenous Innovation and Health Equity Apply for MP CPI 21 007 Funding Number: MP CPI 21 007 Agency: Department of Health and Human Services, Office of the Assistant Secretary for Health Category: Health Funding Amount: $1,000,000 |
| State, Local, Territorial, and Tribal (SLTT) Partnership Programs to Reduce Maternal Deaths due to Violence Apply for WH AST 21 003 Funding Number: WH AST 21 003 Agency: Department of Health and Human Services, Office of the Assistant Secretary for Health Category: Health Funding Amount: $300,000 |
| State, Local, Territorial, and Tribal (SLTT) Partnership Programs to Reduce Maternal Deaths due to Violence Apply for WH AST 21 002 Funding Number: WH AST 21 002 Agency: Department of Health and Human Services, Office of the Assistant Secretary for Health Category: Health Funding Amount: $300,000 |
| Strengthening Public Health Systems and Services through National Partnerships to Improve and Protect the Nation's Health Apply for CDC RFA OT18 18020403SUPP21 Funding Number: CDC RFA OT18 18020403SUPP21 Agency: Department of Health and Human Services, Centers for Disease Control - OSTLTS Category: Health Funding Amount: Case Dependent |
| Service Area Competition Apply for HRSA 22 005 Funding Number: HRSA 22 005 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Framework to Address Health Disparities through Collaborative Policy Efforts: Coordinating Center Apply for MP CPI 21 003 Funding Number: MP CPI 21 003 Agency: Department of Health and Human Services, Office of the Assistant Secretary for Health Category: Health Funding Amount: $500,000 |
| Framework to Address Health Disparities through Collaborative Policy Efforts: Demonstration Projects Apply for MP CPI 21 004 Funding Number: MP CPI 21 004 Agency: Department of Health and Human Services, Office of the Assistant Secretary for Health Category: Health Funding Amount: $375,000 |
| Promoting Vaccine Confidence in Local Communities through Partnership with Regional Health Offices Apply for NV VSR 21 001 Funding Number: NV VSR 21 001 Agency: Department of Health and Human Services, Office of the Assistant Secretary for Health Category: Health Funding Amount: $125,000 |
| American Rescue Plan Act (ARP) of 2021: Section 9813 State Planning Grants for Qualifying Community-Based Mobile Crisis Intervention Services Apply for CMS 2I2 21 001 Funding Number: CMS 2I2 21 001 Agency: Department of Health and Human Services, Centers for Medicare Medicaid Services Category: Health Funding Amount: $1,000,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA TS19 19010301SUPP21", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.